1177:HKG
Sino Biopharmaceutical Ltd
5,42 HK$
arrow_downward
−0,73%(−0,040) 1 p
30. apr, 16:08:11 GMT +8 · HKD
search
Kõik sümbolid
1 p
5 p
1 kuu
6 kuud
YTD
1 a
5 a
MAX
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse 1177 põhistatistika genereerimine…
Ava
5,42 HK$
Kõrge
5,49 HK$
Madal
5,41 HK$
Turu kapit.
101,60 mld
Keskm. maht
78,27 mln
Maht
66,45 mln
Dividend
1,85%
Kvartaalne dividend
0,03 HK$
Dividendikuupäev
29. aug 2025
Hinna ja tulu suhe
36,36
52 näd kõrgeim
9,12 HK$
52 näd madalaim
3,74 HK$
Aktsiatulu
0,15 HK$
Käibivad aktsiad
12,64 mld
Töötajate arv
21 tuh
Uudised
Erinevatest veebiallikatest
TipRanks
·
1 päeva eest
Sino Biopharmaceutical Plans Board Changes Ahead of 2026 AGM
Profiil
Sino Biopharmaceutical Limited, shortly Sino Biopharm, is a pharmaceutical conglomerate in China. The Company was listed on the Hong Kong Stock Exchange in 2000 and included in 2013 as a constituent stock of MSCI Global Standard Indices – MSCI China Index, Hang Seng Index in 2018, Hang Seng China Enterprises Index in 2019, and Hang Seng Connect Biotech 50 Index and Hang Seng China 25 Index in 2020.
The Group’s principal subsidiaries include: Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Beijing Tide Pharmaceutical Co. Ltd., Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. and invoX Pharma Limited. Its products including biopharmaceutical and chemical medicines are used in a host of therapeutic areas, such as tumors, liver diseases, respiratory system diseases and surgery/analgesia. Wikipedia
Teave üksuse Sino Biopharmaceutical Ltd kohta
AI genereeritud sisu võib sisaldada vigu. Lisateave